← All organizations
Highest phase reached
Phase 1
First clinical trial
Aug 1, 2022Last known activity
Nov 1, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 4 trials)
Phase 1 (3 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Recent trials (9)
- NCT06142708CollaboratorN/ANov 1, 2023
- NCT05980091Lead sponsorPhase 1Sep 22, 2023
- NCT05980091Overall official - principal investigatorPhase 1Sep 22, 2023
- NCT05969795Overall official - principal investigatorPhase 1Sep 5, 2023
- NCT05969795Lead sponsorPhase 1Sep 5, 2023
- NCT05969795Reponsible party - principal investigatorPhase 1Sep 5, 2023
- NCT05330130Lead sponsorPhase 1Aug 1, 2022
- NCT05330130Reponsible party - principal investigatorPhase 1Aug 1, 2022
- NCT05330130Overall official - principal investigatorPhase 1Aug 1, 2022
Details
- Last known activity
- Nov 1, 2023